“Ask Dr. David” (COVID) – Thoughts on the Upcoming FDA Meeting to Discuss COVID-19 Vaccine Approval
October 19, 2020
The FDA is holding an advisory committee meeting October 22, 2020 to discuss the approval process for COVID-19 vaccines. Though public comments were permitted (and needed to be submitted by October 15, 2020), the FDA did virtually no public outreach to solicit input from stakeholders who have valid input to offer on issues affecting the vaccine trials and approval process. When Dr. David learned of the meeting, and the call for public comments, he decided to submit formal comments on what he believes the FDA could do to improve public confidence in the forthcoming COVID-19 vaccines. In this video, Dr. David discusses the content of the letter he submitted to the FDA’s advisory committee.
You can read Dr. David’s letter HERE.
You can view the FDA online web conference meeting at:
– or –
Dr. David Berger (“Dr. David”), a Board Certified Pediatrician with over 20 years of experience as a clinician, has developed a national reputation in wholistic pediatric primary care. Dr. David is considered Tampa Bay area’s leading authority on medical cannabis for adults and children, and is one of the nation’s most experienced pediatricians using medical cannabis to help facilitate the treatment of children with chronic conditions.
Dr. David graduated from The Medical College of Pennsylvania in 1994 and completed his pediatric residency at the University of South Florida/Tampa General Hospital where he first began utilizing wholistic therapies. Dr. David has been in private practice since 1997 and in 2005 opened Wholistic Pediatrics & Family Care, his medical practice in Tampa, Florida. In 2010, Dr. David was appointed Assistant Professor at the University of South Florida College of Nursing. In 2016, he launched Wholistic ReLeaf to help qualified patients become certified to use medical cannabis.